American International Group’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,516
Closed -$64K 3365
2022
Q1
$64K Sell
5,516
-388
-7% -$4.62K ﹤0.01% 2759
2021
Q4
$108K Sell
5,904
-178
-3% -$2.26K ﹤0.01% 2684
2021
Q3
$72K Sell
6,082
-144
-2% -$2.1K ﹤0.01% 2916
2021
Q2
$107 Buy
6,226
+2,697
+76% +$51.3K ﹤0.01% 2857
2021
Q1
$65 Buy
3,529
+9
+0.3% +$189 ﹤0.01% 2912
2020
Q4
$66 Sell
3,520
-101
-3% -$2.18K ﹤0.01% 2860
2020
Q3
$76K Buy
3,621
+548
+18% +$12.8K ﹤0.01% 2678
2020
Q2
$89K Sell
3,073
-257
-8% -$7.74K ﹤0.01% 2600
2020
Q1
$117K Sell
3,330
-193
-5% -$6.24K ﹤0.01% 2217
2019
Q4
$86K Buy
+3,523
New +$61.8K ﹤0.01% 2704

Other funds holding OYST

American International Group's OYST Position: Q2 2022 in Review

American International Group sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2022, closing a stake of 5,516 shares — an estimated $64K sold.

American International Group first reported a position in OYST in Q4 2019 and held it in 10 quarters. The position peaked at $117K in Q1 2020. 61 funds tracked by Wall St. Rank hold OYST as of Q2 2022.

  • American International Group reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 5,516 Oyster Point Pharma, Inc. Common Stock shares in Q2 2022, an estimated $64K.
  • American International Group first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 10 quarters.
  • American International Group's Oyster Point Pharma, Inc. Common Stock position peaked at $117K in Q1 2020.
  • 61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.